Bruker Cellular Analysis, Inc. Quarterly Operating Income (Loss) in USD from Q2 2019 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Bruker Cellular Analysis, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2019 to Q2 2023.
  • Bruker Cellular Analysis, Inc. Operating Income (Loss) for the quarter ending June 30, 2023 was -$47.2M, a 84.8% decline year-over-year.
  • Bruker Cellular Analysis, Inc. Operating Income (Loss) for the twelve months ending June 30, 2023 was -$121M, a 43.3% decline year-over-year.
  • Bruker Cellular Analysis, Inc. annual Operating Income (Loss) for 2022 was -$98.1M, a 38.5% decline from 2021.
  • Bruker Cellular Analysis, Inc. annual Operating Income (Loss) for 2021 was -$70.8M, a 75.2% decline from 2020.
  • Bruker Cellular Analysis, Inc. annual Operating Income (Loss) for 2020 was -$40.4M, a 144% decline from 2019.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 -$121M -$47.2M -$21.7M -84.8% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-14
Q1 2023 -$99.6M -$22.8M -$1.56M -7.32% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-15
Q4 2022 -$98.1M -$29.7M -$11.9M -66.7% Oct 1, 2022 Dec 31, 2022 10-K 2023-02-23
Q3 2022 -$86.2M -$21.5M -$1.56M -7.79% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-08
Q2 2022 -$84.6M -$25.5M -$7.7M -43.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-14
Q1 2022 -$76.9M -$21.3M -$6.12M -40.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q4 2021 -$70.8M -$17.8M -$5.98M -50.5% Oct 1, 2021 Dec 31, 2021 10-K 2023-02-23
Q3 2021 -$64.8M -$20M -$11.8M -144% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-08
Q2 2021 -$53M -$17.8M -$5.7M -46.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$47.3M -$15.1M -$6.92M -84.1% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 -$40.4M -$11.8M Oct 1, 2020 Dec 31, 2020 10-K 2023-02-23
Q3 2020 -$8.18M -$3.91M -91.3% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$12.2M -$6.55M -117% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-11
Q1 2020 -$8.23M Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-11
Q3 2019 -$4.28M Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 -$5.6M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.